Skip to main content
SpringerLink
Log in

Ethics and Governance of Stem Cell Banks

  • Protocol
  • First Online:
Stem Cell Banking

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1590))

Abstract

This chapter examines the ethical principles and governance frameworks for stem cell banks. Good governance of stem cell banks should balance facilitation of the clinical use of stem cells with the proper respect and protection of stem cell sample providers and stem cell recipients and ensure compliance with national regulatory requirements to foster public trust in the use of stem cell technology. Stem cell banks must develop with regard to the science, the needs of scientists, and the requirements of the public, which will benefit from this science. Given the international reach of this promising research and its clinical application, it is necessary for stem cell bank governance frameworks to be harmonized across jurisdictions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Cancer Society at http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/bonemarrowandperipheralbloodstemcelltransplant/stem-cell-transplant-types-of-transplants

  2. Waldby C, Salter B (2008) Global governance in human embryonic stem cell science: standardisation and bioethics in research and patenting. Studies in Ethics, Law, and Technology 2(1):1–2

    Article  Google Scholar 

  3. Webster A, Eriksson L (2008) Governance-by-standards in the field of stem cells: managing uncertainty in the world of basic innovation. New Genet Soc 27:99–111

    Article  Google Scholar 

  4. Chen H (2009) Stem cell governance in China: from bench to bedside? New Genet Soc 28:267–282

    Article  CAS  Google Scholar 

  5. Kiatpongsan S, Sipp D (2009) Monitoring and regulating offshore stem cell clinics. Science 323(5921):1564–1565

    Article  CAS  PubMed  Google Scholar 

  6. Isasi R, Knopppers BM (2009) Governing stem cell banks and registries: Emerging Issues. Stem Cell Res 3(2–3):96–105

    Article  PubMed  Google Scholar 

  7. Shwartz SD, Hubschman JP, Heilwell G et al (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379(9817):713–720

    Article  Google Scholar 

  8. http://viacyte.com/products/vc-01-diabetes-therapy/

  9. International Stem Cell Banking Initiative (2009) Consensus guidance for banking and supply of human embryonic stem cells for research purposes. Stem Cell Rev 5:301–314

    Article  Google Scholar 

  10. http://parentsguidecordblood.org

  11. https://www.lifebankusa.com

  12. http://cordblood.cryosite.com/whybankcord

  13. Armitage S, Warwick R, Fehily D et al (1999) Cord blood banking in London: the first 1000 collections. Bone Marrow Transplant 24(2):139–145

    Article  CAS  PubMed  Google Scholar 

  14. Goldschlager T, Ghosh P, Zannettino A et al (2010) Cervical motion preservation using mesenchymal progenitor cells and pentosan polysulfate, a novel chondrogenic agent: preliminary study in an ovine model. Neurosurg Focus 28(6):E4

    Article  PubMed  Google Scholar 

  15. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676

    Article  CAS  PubMed  Google Scholar 

  16. Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872

    Article  CAS  PubMed  Google Scholar 

  17. Chalmers D, Nicol D (2003) Embryonic stem cell research: can the law balance ethical, scientific and economic values (Part 1). Law Hum Genome Rev 18:43–53

    Google Scholar 

  18. http://grants.nih.gov/stem_cells/registry/current.htm

  19. Lockwood M (1985) The Warnock report: a philosophical appraisal. In: Lockwood M (ed) Moral dilemmas in modern medicine. Oxford University Press, Oxford, pp 155–186

    Google Scholar 

  20. Andrews L (1986) The legal status of the embryo. Loyola Law Rev 32(2):357–408

    PubMed  Google Scholar 

  21. Melton D, Daley G, Jennings C (2004) Altered nuclear transfer in stem cell research – a flawed proposal. N Engl J Med 351(27):2791–2792

    Article  CAS  PubMed  Google Scholar 

  22. Heinemann T, Honnefelder L (2002) Principles of ethical decision making regarding embryonic stem cell research in Germany. Bioethics 16(6):530–543

    Article  PubMed  Google Scholar 

  23. Gottweis H (2002) Stem cell policies in the united states and in germany: between bioethics and regulation. Policy Studies J 30(4):444–469

    Article  Google Scholar 

  24. Chalmers D, Nicol D (2003) Embryonic stem cell research: can the law balance ethical, scientific and economic values (Part 2). Law Hum Genome Rev 19:95–101

    Google Scholar 

  25. Löser P, Schirm J, Guhr A et al (2010) Human embryonic stem cell lines and their use in international research. Stem Cells 28:240–246

    PubMed  PubMed Central  Google Scholar 

  26. Nishikaw S-I, Goldstein R, Nierras C (2008) The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 9:725–729

    Article  Google Scholar 

  27. Ying Q-L, Wray J, Nichols J et al (2008) The ground state of embryonic stem cell self-renewal. Nature 453:519–532

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank.aspx

  29. Crook JM, Hei D, Stacey G (2010) The international stem cell banking initiative (ISCBI): raising standards to bank on. In Vitro Cell Dev Biol Anim 46(3–4):169–172

    Article  PubMed  Google Scholar 

  30. Chalmers D (2008) The regulation of embryo and stem cell research in Australia: licensing with a restrictive tilt. J International Biotechnol Law 5(5):177–185

    Article  Google Scholar 

  31. Halliday S (2004) A comparative approach to the regulation of human embryonic stem cell research in Europe. Med Law Rev 12(1):40–69

    Article  Google Scholar 

  32. Gottweis H (2002) Stem cell policies in the united states and Germany: between bioethics and regulation. Policy Studies J 30(4):441–469

    Article  Google Scholar 

  33. Dederer H-G (2006) Regulation of human embryonic stem cell research in germany. J International Biotechnol Law 3:63

    Article  Google Scholar 

  34. Robertson J (2004) Reproductive technology in germany and the united states: an essay in comparative law and bioethics. Columbia J Transnational Law 43:189–227

    Google Scholar 

  35. Human Tissue Act 2004 (UK)

    Google Scholar 

  36. 2004/23/Ec, 2006/17/EC, 2006/86/EC: http://europa.eu/legislation_summaries/public_health/threats_to_health/c11573_en.htm

  37. http://www.ukstemcellbank.org.uk/stem_cell_lines/importing_or_exporting_stem.aspx

  38. Chalmers D (2004) Research involving humans: a time for change? J Law Med Ethics 32(4):583–495

    Article  PubMed  Google Scholar 

  39. Cowen Z. (1986) Law, medicine and biotechnology. Australasian Universities Law Schools Association 41st Conference

    Google Scholar 

  40. http://www.isscr.org/about/index.htm.

  41. International Society for Stem Cell Research (2008) Guidelines for the clinical translation of stem cells http://www.isscr.org.

  42. Hyun I, Lindvall O, Ährlund-Richter L et al (2008) New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 3(6):607–609

    Article  CAS  PubMed  Google Scholar 

  43. http://www.ukstemcellbank.org.uk/international_initiatives.aspx

  44. Andrews PW, Baker D, Benvinisty N et al (2015) Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). Regen Med 10(2 Suppl):1–44

    Article  CAS  PubMed  Google Scholar 

  45. Andrews PW, Arias-Diaz J, Auerbach J et al (2009) Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev 5(4):301–314

    Article  Google Scholar 

  46. http://www.ukstemcellbank.org.uk/policies__guidelines/codes_of_practice.aspx

  47. http://www.ukstemcellbank.org.uk/about_us/governance_of_the_uk_stem_cell.aspx

  48. Stephens N, Atkinsona P, Glasnera P (2008) The UK stem cell bank as performative architecture. New Genet Soc 27:87–98

    Article  Google Scholar 

  49. http://www.ukstemcellbank.org.uk/policies_guidelines/research_use_licence.aspx

  50. http://www.ukstemcellbank.org.uk/policies_guidelines/charging_policy_for_hesc_lines.aspx

  51. Streitz WD, Bennett AB (2003) Material transfer agreements: a university perspective. Plant Physiol 113:10–13

    Article  Google Scholar 

  52. Lei Z, Juneja R, Wright BD (2009) Patents versus patenting: implications of intellectual property protection for biological research. Nat Biotechnol 27:36–40

    Article  CAS  PubMed  Google Scholar 

  53. ISBER (2012) Best practices for repositories collection, storage, retrieval, and distribution of biological materials for research (third revision) Section M2.610

    Google Scholar 

  54. Knoppers B, Isasi R (2010) Stem cell banking: between traceability and identifiability. Genome Med 2:73–80

    Article  PubMed  PubMed Central  Google Scholar 

  55. UK Biobank, Ethics and governance framework, Background documents wellcome trust and medical research council and department of health UK, 10 October 2003.

    Google Scholar 

  56. Boggio A (2005) Charitable trusts and human research genetic databases. Genomics Soc Pol 1:41–49

    Google Scholar 

  57. National Academies Committee on the biological and biomedical application of stem cell research, stem cells and the future of regenerative medicine (Washington DC: National Academies Press; 2001)

    Google Scholar 

  58. International Society for Stem Cell Research (2008) Guidelines for the clinical translation of stem cells. http://www.isscr.org. Recommendations 16–18

  59. http://www.mrc.ac.uk/consumption/groups/public/documents/content/mrc003259.pdf

  60. UK Stem Cell Bank Materials Deposit and Distribution Agreement Clause 2.3: http://www.ukstemcellbank.org.uk/PDF/Materials%20Deposition%20Agreement%20Final(for%20use%20with%20RUL).pdf

  61. Daley G, Richter LA, Auerbach JM et al (2007) The ISSCR guidelines for human embryonic stem cell research. Science 315(5812):603–604

    Article  CAS  PubMed  Google Scholar 

  62. Harvey AJ, Rathjen J, Gardner DK (2013) The metabolic framework of pluripotent stem cells and potential mechanisms of regulation. In: Simon C, Pellicer A, Reijo-Per R (eds) Stem Cells in Reproductive Medicine. Cambridge University Press, Cambridge, pp 164–179

    Chapter  Google Scholar 

  63. http://www.ukstemcellbank.org.uk/about_us/nibsc_and_the_stem_cell_bank.aspx

  64. Chalmers D. (2006) International medical research regulation: from ethics to law. In: McLean S. (ed) First Do No Harm. Ashgate Press, pp. 81–100.

    Google Scholar 

Download references

Acknowledgments

NHMRC Program Grant 490037; ARC Discovery Grant DP11010069 for support.

Author information

Authors and Affiliations

  1. Centre for Law and Genetics, Faculty of Law, University of Tasmania, Room 2178, Faculty of Law Bldg, Hobart, TAS, 7001, Australia

    Donald Chalmers & Dianne Nicol

  2. The Menzies Institute of Medical Research, University of Tasmania, Hobart, TAS, 7001, Australia

    Peter Rathjen

  3. School of Medicine, University of Tasmania, Hobart, TAS, 7001, Australia

    Joy Rathjen

Authors
  1. Donald Chalmers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Rathjen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joy Rathjen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dianne Nicol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Donald Chalmers .

Editor information

Editors and Affiliations

  1. ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer Research Institute, AIIM Facility, Innovation Campus, University of Wollongong, Squires Way, Fairy Meadow, New South Wales, Australia

    Jeremy M. Crook

  2. WiCell Research Institute, Madison, Wisconsin, USA

    Tenneille E. Ludwig

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Chalmers, D., Rathjen, P., Rathjen, J., Nicol, D. (2017). Ethics and Governance of Stem Cell Banks. In: Crook, J., Ludwig, T. (eds) Stem Cell Banking. Methods in Molecular Biology, vol 1590. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6921-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6921-0_7

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-6919-7

  • Online ISBN: 978-1-4939-6921-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation